Efficacy and safety study of fixed-dose combination of ceftriaxone-vancomycin injection in patients with various

Manu Chaudhary1, Sanjay Mohan Shrivastava, Rajesh Sehgal

  • 1Intellectual Scientific Division, R & D Centre, Venus Remedies Limited, Haryana, India.

Current Drug Safety
|August 12, 2008
PubMed

Insights

The fixed-dose combination of Ceftriaxone-Vancomycin effectively treats various bacterial infections. This antibiotic combination showed significant improvement in patients with infections, with no observed liver or kidney toxicity.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Medicine

Background:

  • Bacterial infections pose significant health risks across various tissues.
  • Effective antimicrobial therapy is crucial for managing diverse infections.
  • Evaluating fixed-dose combinations can optimize treatment regimens.

Purpose of the Study:

  • To assess the efficacy and safety of a fixed-dose combination of Ceftriaxone-Vancomycin.
  • To evaluate treatment outcomes in patients with multiple types of bacterial infections.
  • To determine the impact of the combination therapy on key clinical and biochemical markers.

Main Methods:

  • A randomized study involving 305 patients with bacterial infections.
  • Patients received intravenous Ceftriaxone-Vancomycin at 1.5 g B.D. or 3.0 g B.D. for 3-10 days.
  • Clinical cure rates and biochemical parameters (hemoglobin, leukocyte count, ESR, renal and liver function tests) were monitored.

Main Results:

  • 70% of patients achieved cure within seven days.
  • Significant reductions in total leukocyte count and erythrocyte sedimentation rate indicated infection resolution.
  • No adverse effects on hemoglobin, urea, creatinine, or liver enzymes were observed.

Conclusions:

  • The fixed-dose combination of Ceftriaxone-Vancomycin is an effective treatment for various bacterial infections.
  • The therapy demonstrated a favorable safety profile, with no significant toxicity to the liver or kidneys.
  • Patients tolerated the drug well, with minimal major adverse effects reported.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...